The global analysis of genomic variants, gene and miRNA expression, aberrant methylation, and proteomic profiles unraveled that mutations in BRAF and RAS, together with RET-PTC fusions, are the most common genetic alterations in both FTC and PTC. The gene discussed is CCDC6; the disease is thyroid cancer, nonmedullary, 2.